Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
198 |
|
| Actual shortage: | 8 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 26 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Actual shortage | 2024-06-06 | 2024-06-08 | 229851 |
| METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-01-02 | 2019-02-09 | 70778 |
| METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-06-18 | 2019-07-03 | 86984 |
| METRONIDAZOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-07-16 | 2019-08-09 | 89429 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2023-12-07 | 2023-12-12 | 212704 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2023-12-07 | 2024-02-02 | 212707 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-06 | 2024-02-08 | 218656 |
| METRONIDAZOLE INJECTION, USP | 5MG | SOLUTION | Resolved | 2024-02-27 | 2024-03-19 | 220718 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2020-09-02 | 2020-09-17 | 123592 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2022-12-02 | 2022-12-12 | 177050 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2023-02-06 | 2023-11-01 | 183714 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-01-12 | 2018-02-06 | 35770 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-08-13 | 2018-08-29 | 58038 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-12-14 | 2018-12-20 | 69676 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2019-07-16 | 2019-11-29 | 89426 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | Avoided shortage | 2023-11-17 | 2024-04-11 | 210780 |
| 70% DEXTROSE INJECTION USP | 70G | SOLUTION | Resolved | 2021-10-13 | 2021-11-05 | 147116 |
| TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-09-07 | 2021-10-02 | 145280 |
| TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-09-23 | 2021-10-02 | 146106 |
| TRAVASOL | 730MG 500MG 40MG 680MG 1.15G 1.03G 2.07G 180MG 420MG 480MG 580MG 600MG 580MG 400MG 560MG | SOLUTION | Resolved | 2021-10-13 | 2021-11-05 | 147113 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7240 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7264 |
| ACID CONCENTRATE 2163 | 90G 10.8G 2.14G 6.24G 10.06G 275G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7249 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |